# Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary Care

> **NCT00950534** · PHASE4 · TERMINATED · sponsor: **Sanofi** · enrollment: 25 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** INSULIN GLARGINE (HOE901)
- **DRUG:** Oral Anti Diabetics (OAD)

## Key facts

- **NCT ID:** NCT00950534
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** due to poor recruitment
- **Last updated:** 2011-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00950534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00950534, "Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary Care". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00950534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*